193 related articles for article (PubMed ID: 29979395)
1. A PRISMA-compliant systematic review and network meta-analysis on the efficacy between different regimens based on Tripterygium wilfordii Hook F in patients with primary nephrotic syndrome.
Wang XB; Dai EL; Xue GZ; Ma RL
Medicine (Baltimore); 2018 Jul; 97(27):e11282. PubMed ID: 29979395
[TBL] [Abstract][Full Text] [Related]
2. Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome.
Chen Y; Gong Z; Chen X; Tang L; Zhao X; Yuan Q; Cai G
Cochrane Database Syst Rev; 2013 Aug; (8):CD008568. PubMed ID: 23934958
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of Tripterygium wilfordii Hook F in the immunosuppressive treatment of IgA nephropathy.
Chen YZ; Gao Q; Zhao XZ; Chen XM; Zhang F; Chen J; Xu CG; Sun LL; Mei CL
Intern Med; 2010; 49(19):2049-55. PubMed ID: 20930429
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Tripterygium wilfordii Hook F on animal model of Diabetic Kidney Diseases: A systematic review and meta-analysis.
Jin D; Yu M; Li X; Wang X
J Ethnopharmacol; 2021 Dec; 281():114536. PubMed ID: 34419607
[TBL] [Abstract][Full Text] [Related]
5. Tripterygium wilfordii Hook F treatment for idiopathic refractory nephrotic syndrome in adults: a meta-analysis.
Xu G; Tu W; Jiang D; Xu C
Nephron Clin Pract; 2009; 111(4):c223-8. PubMed ID: 19287181
[TBL] [Abstract][Full Text] [Related]
6. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Liu ID; Willis NS; Craig JC; Hodson EM
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31749142
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Tripterygium Wilfordii Hook. F for Connective Tissue Disease-Associated Interstitial Lung Disease:A Systematic Review and Meta-Analysis.
Li Y; Zhu W; He H; Garov YA; Bai L; Zhang L; Wang J; Wang J; Zhou X
Front Pharmacol; 2021; 12():691031. PubMed ID: 34177599
[No Abstract] [Full Text] [Related]
8. Tripterygium wilfordii Hook F combination therapy with methotrexate for rheumatoid arthritis: An updated meta-analysis.
Luo Y; Hou X; Xi A; Luo M; Wang K; Xu Z
J Ethnopharmacol; 2023 May; 307():116211. PubMed ID: 36706936
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of Tripterygium wilfordii Hook F for CKD in Mainland China: A systematic review and meta-analysis.
Wang D; Zhao XH; Cui Y; Zhang TT; Wang F; Hu YH
Phytother Res; 2018 Mar; 32(3):436-451. PubMed ID: 29193402
[TBL] [Abstract][Full Text] [Related]
10. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Hodson EM; Wong SC; Willis NS; Craig JC
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD003594. PubMed ID: 27726125
[TBL] [Abstract][Full Text] [Related]
11. Tripterygium wilfordii Hook. f. versus azathioprine for prevention of postoperative recurrence in patients with Crohn's disease: a randomized clinical trial.
Zhu W; Li Y; Gong J; Zuo L; Zhang W; Cao L; Gu L; Guo Z; Li N; Li J
Dig Liver Dis; 2015 Jan; 47(1):14-9. PubMed ID: 25445405
[TBL] [Abstract][Full Text] [Related]
12. Tripterygium wilfordii Hook F as Maintenance Treatment for Crohn's Disease.
Sun J; Shen X; Dong J; Wang H; Zuo L; Zhao J; Zhu W; Li Y; Gong J; Li J
Am J Med Sci; 2015 Nov; 350(5):345-51. PubMed ID: 26473333
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial.
Goldbach-Mansky R; Wilson M; Fleischmann R; Olsen N; Silverfield J; Kempf P; Kivitz A; Sherrer Y; Pucino F; Csako G; Costello R; Pham TH; Snyder C; van der Heijde D; Tao X; Wesley R; Lipsky PE
Ann Intern Med; 2009 Aug; 151(4):229-40, W49-51. PubMed ID: 19687490
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of 13 immunosuppressive agents for idiopathic membranous nephropathy in adults with nephrotic syndrome: a systematic review and network meta-analysis.
Zheng Q; Yang H; Liu W; Sun W; Zhao Q; Zhang X; Jin H; Sun L
BMJ Open; 2019 Sep; 9(9):e030919. PubMed ID: 31511292
[TBL] [Abstract][Full Text] [Related]
15. Tripterygium wilfordii Hook F versus conventional synthetic disease-modifying anti-rheumatic drugs as monotherapy for rheumatoid arthritis: a systematic review and network meta-analysis.
Wang HL; Jiang Q; Feng XH; Zhang HD; Ge L; Luo CG; Gong X; Li B
BMC Complement Altern Med; 2016 Jul; 16():215. PubMed ID: 27411429
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of Tripterygium wilfordii hook F for chronic urticaria: a systematic review and meta-analysis.
Liu L; Zhao H; Sun X; Zheng Q; Luo Y; Ru Y; Zhang Y; Chen X; Zhu B; Yin C; Li B; Li X
BMC Complement Altern Med; 2018 Aug; 18(1):243. PubMed ID: 30170584
[TBL] [Abstract][Full Text] [Related]
17. A meta-analysis of effects and safety of Tripterygium wilfordii polyglycoside in the treatment of IgA nephropathy.
Wang RX; Liao BQ; Chen W; Zhang YM; Tang XH; Xie FH
Eur Rev Med Pharmacol Sci; 2022 Dec; 26(23):8756-8770. PubMed ID: 36524494
[TBL] [Abstract][Full Text] [Related]
18. Study on toxicity/efficacy related substances and metabolic mechanism of Tripterygium wilfordii Hook. f based on O2LPS correlation analysis.
Song L; Wang J; Nie J; Zhang Y; Han R; Liu H; Ma N; Yang Z; Li Y
J Ethnopharmacol; 2024 Jan; 318(Pt B):116949. PubMed ID: 37506782
[TBL] [Abstract][Full Text] [Related]
19. The Effectiveness and Safety of
Zhou YY; Xia X; Peng WK; Wang QH; Peng JH; Li YL; Wu JX; Zhang JY; Zhao Y; Chen XM; Huang RY; Jakobsson PJ; Wen ZH; Huang QC
Front Pharmacol; 2018; 9():356. PubMed ID: 29713281
[No Abstract] [Full Text] [Related]
20. Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial.
Lv QW; Zhang W; Shi Q; Zheng WJ; Li X; Chen H; Wu QJ; Jiang WL; Li HB; Gong L; Wei W; Liu H; Liu AJ; Jin HT; Wang JX; Liu XM; Li ZB; Liu B; Shen M; Wang Q; Wu XN; Liang D; Yin YF; Fei YY; Su JM; Zhao LD; Jiang Y; Li J; Tang FL; Zhang FC; Lipsky PE; Zhang X
Ann Rheum Dis; 2015 Jun; 74(6):1078-86. PubMed ID: 24733191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
